C-squared Pharma Ltd, based in Ireland, is a pharmaceutical company.
One of their notable products is HOMATROPINE METHYLBROMIDE USP, with a corresponding US DMF Number 31086.
Remarkably, this DMF maintains an Active status since its submission on December 16, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 15, 2017, and payment made on January 03, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II